Joerg Kempfert

Joerg Kempfert

Cardiac surgeon
German Heart Institute Berlin - Berlin, Germany

Latest contributions

PCR's Got Talent - Round 1 - Session 1

16 May 2023 – From EuroPCR 2023

Have you attended this session and wish a memory boost? Look at the slides presented by the speakers and review what is important to remember.

Interventional cardiology abstracts

Defining together the ideal TAVI platform of the future

16 May 2023 – From EuroPCR 2023

How to successfully plan and access a TAVI procedure using ultrasound guidance? How to close a TAVI procedure using suture-based vessel closure devices? How to manage vascular complications during and after TAVI procedures? Join the speakers in this brainstorming session and imagine what tomorrow's ideal TAVI...

Treatment of multi-valve disease

29 Nov 2022 – From PCR London Valves 2022

Get a look at these presentations to learn more about the basic haemodynamic interactions between different valve lesions, the existing surgical standards (and evolving transcatheter standards) for the treatment of multi-valve disease, and to discover a selection of cases that demonstrate the importance of clear indications and appropriate timing...

Treatment of multi-valve disease

Therapy of valvular heart diseases: a patient-centred innovation journey

27 Nov 2022 – From PCR London Valves 2022

Join a team of experts as they review together the complete spectrum of valvular heart disease and ways in which we can manage it using emerging novel technologies.

Primary mitral regurgitation: treatment options when the anatomy is simple

27 Nov 2022 – From PCR London Valves 2022

Consult this session to learn about the different technical aspects and limitations for both surgical and catheter-based techniques and to understand the design and implications of two current RCTs comparing interventional and surgical techniques in patients with primary mitral regurgitation.

Primary mitral regurgitation: treatment options when the anatomy is simple

Primary mitral regurgitation: treatment options when the anatomy is complex

27 Nov 2022 – From PCR London Valves 2022

Take a look at these presentations to learn more about complex primary mitral regurgitation (and how to differentiate it from simple disease), to understand why it is complex and to know what the treatment options are.

Primary mitral regurgitation: treatment options when the anatomy is complex

Bicuspid prevalence in China

31 Oct 2022

Discover the replay of this PCR webinar on TAVI with M. Chen, J. Kempfert, J.Z. Junjie, Y. Tang and Y. Wang.

TAVI in bicuspid aortic valve patients: SAPIEN 3 platform, a safe and efficient option

15 Apr 2021

Discover the replay of this webinar on TAVI with D. Blackman, B. Garcia Del Blanco, J. Kempfert and R. Parma

Valve-in-valve could be a challenging procedure

19 May 2022 – From EuroPCR 2022

Watch this session on valve-in-valve to learn how to deal with challenging procedures: FIH experience with first dedicated transcatheter leaflet splitting device, bioprosthesis haemodynamics and coronary flow after TAVI in TAVI, and simultaneous complex transcatheter treatment for degenerated prosthetic valves. 

Valve-in-valve could be a challenging procedure

Open the pass: interventions to facilitate transfemoral TAVI in calcified access

19 May 2022 – From EuroPCR 2022

Consult this session to discover some interventions to facilitate transfemoral TAVI in challenging situations, such as: coarctation and aortic stenosis with very high surgical risk, severe aortic stenosis with large infra-renal abdominal aneurysm, severe circumferential calcified bilateral iliac stenosis with thick protruding nodules, and much more!

Open the pass: interventions to facilitate transfemoral TAVI in calcified access

TAVI durability: important considerations for patient lifetime management

18 May 2022 – From EuroPCR 2022

How should I treat? - TAVI in bicuspid aortic valve stenosis: tips and tricks for an optimal result

06 Apr 2022

A 70-year-old male patient was referred to hospital with signs of acute myocardial infarction. Echocardiography confirmed impaired left ventricular function and severe low flow, low gradient aortic valve stenosis. Would you go for surgical aortic valve replacement or transfemoral TAVI?

Author

Joerg Kempfert
Christoph Klein

Author

Christoph Klein
Marian Kukucka

Author

Marian Kukucka
Karel Van Praet

Author

Karel Van Praet
Axel Unbehaun

Author

Axel Unbehaun

From TAVI to mitral and tricupid - Applying evidence to expand patients' treatment options - Part 2 - Securing long-term patient options

22 Nov 2021 – From PCR London Valves

Nowadays, there is an increasing range of treatment options as far as tricuspid and mitral regurgitations are concerned, as you can notice in this session broadcast at PCR London Valves 2021 Congress, focusing on this topic area. Watch it now if you wish to understand how key...

From TAVI to mitral and tricupid - Part 2 - Securing long-term patient options

TAVI in bicuspid aortic valve patients. SAPIEN 3 platform, a safe and efficient option

19 May 2021 – From EuroPCR 2021

Watch this session presented by Philippe Genereux, Didier Tchetche, Joerg Kempfer, Radoslaw Parma and Christoph Klein in order to understand which patients with bicuspid aortic valve are suitable for TAVI vs. SAVR, to learn about Edwards SAPIEN 3 being utilisation in patients with bicuspid aortic valve, and to know more about the...

TAVI in bicuspid aortic valve patients. SAPIEN 3 platform, a safe and efficient option